XML 31 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash Flows From Operating Activities:    
Net loss $ (137,731) $ (134,098)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 13,208 15,199
Gain on change in fair value of SAFE and warrant liabilities (17,887) (14,471)
Loss on change in fair value of the FPA Put Option and the Fixed Maturity Consideration liabilities 23,510 44,300
Loss on change in fair value of Convertible Note 11,894 0
Provisions for losses on trade and other receivables, net of recoveries 961 700
Depreciation of property, plant and equipment 5,592 5,452
Amortization of discount on debt security investment (854) (1,301)
Non-cash lease expense 1,713 1,526
Non-cash recognition of licensing revenue (11,532) (1,805)
Loss from equity method investees, net 14,234 2,902
Gain from disposal of PPE (25) 0
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax 284 (182)
Changes in operating assets and liabilities:    
Accounts receivable, net 557 104
Contract assets 9,162 (10,049)
Accrued interest on debt investment 183 (266)
Other assets (2,066) (2,658)
Accounts payable and accrued salaries and wages (1,790) (4,991)
Contract liabilities 311 95
Operating lease liabilities 641 (337)
Other liabilities 1,143 2,220
Net cash used in operating activities (89,060) (97,296)
Cash Flows From Investing Activities:    
Purchase of property, plant and equipment (5,312) (8,553)
Proceeds from disposal of property, plant and equipment 25 0
Purchase of debt securities (27,083) (93,858)
Proceeds from maturity of debt securities 60,722 50,000
Purchase of additional interest in equity method investment 0 (288)
Origination of related party loan 0 (5,212)
Net cash provided by/(used in) investing activities 28,352 (57,911)
Cash Flows From Financing Activities:    
Proceeds from the Business Combination and PIPE, net of transaction expenses 0 213,381
FPA prepayment 0 (60,096)
Proceeds from exercise of options 300 2,550
Repurchase of equity instruments of the Company (48) (7,650)
Payments For Settlement Of Forward Purchase Agreement (10,039) 0
Proceeds from issuance of Convertible Note, net 40,000 0
Net cash provided by financing activities 30,213 148,185
Effects of currency translation on cash, cash equivalents and restricted cash (52) (404)
Net decrease in cash, cash equivalents and restricted cash (30,547) (7,426)
Cash, cash equivalents and restricted cash at beginning of period 76,284 83,710
Cash, cash equivalents and restricted cash at end of period 45,737 76,284
Supplemental disclosure of non-cash investing and financing activities:    
Acquisition of property, plant and equipment under accounts payable 132 279
Right-of-use asset additions 10,194 12,866
Non-cash partial reversal of FPA upon settlement 24,084 0
Third-party issuance costs for the Convertible Note 3,169 0
Reclassification of capitalized costs related to the business combination to equity 0 1,514
Cashless conversion of warrants on preferred shares 0 5,890
Recognition of public and private warrant liabilities in the Business Combination 0 4,624
Reclassification of AM SAFE warrant to equity 0 1,800
Conversion of AM SAFE liability into common stock 0 29,730
Conversion of Legacy LanzaTech NZ, Inc. preferred stock and in-kind dividend into common stock 0 722,160
Reclassification of FPA Warrants to equity $ 0 $ 3,063